Pfizer Inc. (NYSE:PFE) is one of the the best healthcare stocks under $50 to invest. Pfizer Inc. (NYSE:PFE) announced on February 6 that the US Food and Drug Administration has accepted and granted priority review for its supplemental biologics license application for HYMPAVZI® for the expansion of the approved indication to include the treatment of patients with hemophilia A or B aged 6 years and older with inhibitors and pediatric patients with hemophilia A or B without inhibitors. HYMPAVZI is currently approved for the treatment of patients 12 years of age and older with hemophilia A without factor VIII inhibitors or hemophilia B without factor IX inhibitors in the United States.

Pfizer Inc. (NYSE:PFE) further reported that the FDA has set an action date for the Prescription Drug User Fee Act in the second quarter of 2026. If approved, HYMPAVZI would offer a combination of bleeding protection with simple once-weekly subcutaneous injection administration that requires minimal preparation without the need for routine monitoring of these treatment-related patient populations.

In another development, Pfizer Inc. (NYSE:PFE) announced on February 5th the launch of its TrumpRx program to make innovative medicines more accessible and affordable for Americans. The program offers Americans substantial discounts off list prices on more than 30 drugs. Management reported that the initiative is part of Pfizer Inc.’s broader Most Favored Nation deal. (NYSE:PFE) with the US government.

Pfizer Inc. (NYSE:PFE) is a global biopharmaceutical company that manufactures, develops, markets and sells biopharmaceutical products worldwide. Advances wellness, prevention, treatment and care in emerging and developing markets.

While we recognize PFE’s potential as an investment, we believe some AI stocks offer greater upside potential and less downside risk. If you’re looking for an extremely undervalued AI stock that will also benefit significantly from Trump-era tariffs and the onshoring trend, check out our free report on the best short term AI stock.

READ THE FOLLOWING: 30 stocks that should double in 3 years i 11 Hidden AI Stocks to Buy Right Now.

Disclosure: no. This article is originally published in Monkey Insider.